Ru Feng
- Molecular Biology top 5%
- Pharmacology top 1%
- Pharmacology top 0.5%
- Plant Science top 10%
- Immunology top 10%
- Topics
- Berberine and alkaloids research (8 papers)Acute Myeloid Leukemia Research (8 papers)Ginseng Biological Effects and Applications (5 papers)
- Cited by
- PharmacologyMolecular Biology
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Ru Feng
80 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Molecular Biology 1.4k
- Pharmacology 700
- Pharmacology 466
- Plant Science 317
- Immunology 289
Countries citing papers authored by Ru Feng
This map shows the geographic impact of Ru Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ru Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ru Feng more than expected).
Fields of papers citing papers by Ru Feng
This network shows the impact of papers produced by Ru Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ru Feng. The network helps show where Ru Feng may publish in the future.
Co-authorship network of co-authors of Ru Feng
This figure shows the co-authorship network connecting the top 25 collaborators of Ru Feng. A scholar is included among the top collaborators of Ru Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ru Feng. Ru Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 28 | |
| 8 | 11 | |
| 9 | 24 | |
| 10 | 2 | |
| 11 | 1 | |
| 12 | 0 | |
| 13 | 3 | |
| 14 | 8 | |
| 15 | 36 | |
| 16 | 68 | |
| 17 | 243 | |
| 18 | 180 | |
| 19 | Track of Research on Elements of Technology Philosophy in China——Based on Statistical Descriptions of CNKI Database | 0 |
| 20 | NMR STUDIES ON THE STRUCTURE OF A NEW DENUDATINE DITERPENOID-TYPE ALKALOID | 1 |
About Ru Feng
Ru Feng is a scholar working on Hematology, Pharmacology and Genetics, having authored 92 papers that have together received 2.9k indexed citations. Recurring topics across this work include Berberine and alkaloids research (8 papers), Acute Myeloid Leukemia Research (8 papers) and Ginseng Biological Effects and Applications (5 papers). The work is most often cited by research in Pharmacology (466 citations), Pharmacology (700 citations) and Molecular Biology (1.4k citations). Ru Feng has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Huafeng Xie, Thomas Graf, Min Ye, Jian‐Dong Jiang, Chi‐Yu He, Jia‐Wen Shou, Chao Ma, Min Huang, Ester Sànchez‐Tilló and Sabrina C. Desbordes. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.